Michael Gov has told the Kovid inquiries that it was “Ludicus”, suggesting that he tried to force through a deal to a new ventilator without a proper security check by Electronics Giant Dyson.

In the email, a senior official at the Health Watchdog warned that the former Cabinet Office Minister was trying to “bypassing the regulatory process” in March 2020.

Messages between the employees of the Medicine and Healthcare Products Regulatory Agency (MHRA) said that Mr. Gov was “not appreciated the level of risk” and “fully unrealistic” was working over time.

At that time an provisional order for 10,000 machines was placed, but the deal was terminated after failing to win the Diocese regulatory approval.

No public money was spent on the prototype.

Dyson said it was never intended to earn profit from the enterprise and wrote around £ 20M in research and development costs.

In March 2020, as Kovid was spreading in northern Italy, a frantic attempt was made by health officials to catch the ventilator to help patients breathe.

The stock in NHS was between 6,000 and 8,000, but modeling suggested that 30,000 was required by the end of June and 90,000 by November, so that an estimated influx of patients could be faced.

On 16 March 2020, the government launched the ‘ventilator Challenge’ – a drive to develop domestic UK suppliers to develop new machines or encourage existing designs.

The project was supervised by the cabinet office officials and included the MHRA, which helped prepare the initial specifications and squeezed a approval process, usually 18–24 months in just a few weeks.

Several major companies were involved, including car manufacturers Ford and McLaren and Electronics Giane Dyson.

At that time, the company’s founder Sir James Dyson held several telephone talks with government officials including the then Prime Minister Boris Johnson.

Kovid inquiry was shown WhatsApp messages were then sent between ministers and government advisors Sir was worried about the speed of the project, suggesting James.

On 20 March 2020, Mr. Johnson wrote that “Dyson (Tha) Fricing” and “on this day action”.

After minutes, former Health Secretary Matt Hancock replied, “I have found the same. I will talk to Dyson and Michael (Gov) and sort it.”

When asked about the deal in the investigation, the then Chief Commercial Officer of the government, Sir Gareth Rice Williams said it was the only example he could remember in the epidemic where he was asked to make a contract “against” commercial guidance “.

Five days later, on 25 March, Boris Johnson wrote another WhatsApp message to the same group Saying that: “A ventilator is ready to go to Dyson … It is safe, effective and loses low oxygen. RHYS Williams has blocked it under the misconception that passes through the oxygen motor. It is a total B **** CKS.”

He accused the authorities of “fidling during Rome Burns” and said: “Sorry, but I am on a mission. Dyson knows what he is doing and will not put his global brand prestige at risk.”

Sir Gareth said, at that time, the Dyson Prototype pushed the air directly into the patients’ lungs from a fan, something that could cause safety concerns.

The Dyson team later “fixed” that part of the design, he said.

Later on 25 March, Sir Gareth Written to Sir John ManzoniA top civil servant at the cabinet office stated that Michael Gov was “urged that we give an order with Dyson … contingency to pass clinical and pass MHRA approval.”

An provisional £ 100,000 order was then placed for the diocen prototype, and A Email from Michael Gov’s private office Determine several tasks that need to be included quickly: “MHRA and Sir Gareth Rhys Williams to ensure this by the end of Friday, (that) the diocery product has been tested and approved by MHRA … (and) The final product has been started.”

Next day Graeme Tunbridge, director of equipment for MHRA, wrote to colleagues Warning that Michael Gov “was eager to proceed with a timscall proposal with Dyson’s offer that is completely unrealistic.”

He said that Mr. Gov “did not appreciate the level of risk involved in the construction and use of the ventilator” and “wanted to ignore the rapid regulatory process that is placed in place”.

He wrote, “MHRAs are doing everything we can support, but important patients will not cut corners at all when they come on safety issues.”